AllDocs -> cancers

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Referees & Futsal Officer REPORTS TO: Soccer Operations Co-ordinator CURRENT INCUMBENT: VACANT DIRECT REPORTS: n/a AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. Referees ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Information Technology Co-ordinator REPORTS TO: Manager Commercial Services CURRENT INCUMBENT: VACANT DIRECT REPORTS: N/A AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. ...

leukaemia Bone Marrow for Leukaemia Trust ?The Pink Lily Ball? in aid of Bone Marrow for Leukaemia Trust will take place Friday 14 May 2004 in the Burlington Hotel ?Cocktails at 8.00pm? Five Course Dinner & Dancing Music by ?The Heartbeats? Dress Formal ?.. The Pink Lily Ball ORDER FORM Please reserve the following number of tickets _ Tickets @ €150 each ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Assistant Coach – VSF Academy Program REPORTS TO: Coach CURRENT INCUMBENT: VACANT DIRECT REPORTS: n/a AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. Academy Program ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Coach – VSF Academy Program REPORTS TO: Head Coach CURRENT INCUMBENT: VACANT DIRECT REPORTS: Assistant Coach AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. Academy Development ...

APPLICATION FOR IMATINIB MESYLATE FOR TREATMENT OF CHRONIC MYELOID LEUKAEMIA Please send applications and prescriptions to: The Glivec Co-ordinator PHARMAC PO Box 10-254 WELLINGTON Phone: 04 916 7539 Facsimile: 04 916 7571 Email: mary.chesterfield@ pharmac.govt.nz Details of applying practitioner Patient details Title: Mr/Mrs/Miss/Ms/Dr NHI No:. Surname:.... First names: Address:.. ..... .. Gender: Male/Female DOB:.. Phone No:... Details of patient’s General Practitioner Specialty:.. Application to be made, and subsequent prescriptions to be written, by a haematologist or an oncologist. Surname:... First names:.. NZMC registration number:.... Address:. . . Phone No:.. Facsimile No:. Email address:.. Cellphone No:. Name:...... Address:.. ..... ...

leukaemia Anti-CD33 engineered lymphocytes for the treatment of myeloid leukaemia . Dr. Peter J. Nicholls Department of Biosciences University of Kent at Canterbury Acute Myeloid Leukaemia (AML) Characterised by proliferation of myeloid cells in the bone marrow. In the USA, annual incidence of the disease is 2.4 per 100,000 people, increasing to 12.6 per 100,000 at >65 years of age. Prior to 1970, 5 year survival rates <15% Recent refinements in diagnosis/therapy have improved outlook for AML patients. Nevertheless, survival rate for patients <65 years old is just 40%. Source: NEJM 341 (14), 1051 [1999] Clinical Presentation in AML Clinical signs (e.g. fatigue, haemorrage, infection, dyspnea) are initially diverse and non-specific, making diagnosis problematic. Leukaemic infiltration of liver, spleen, skin, lymph ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Head Coach – VSF Academy Program REPORTS TO: Technical Director of Coaching CURRENT INCUMBENT: VACANT DIRECT REPORTS: Coach AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Team Manager – VSF Academy Program REPORTS TO: Head Coach CURRENT INCUMBENT: VACANT DIRECT REPORTS: n/a AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. Academy Development ...

del file contenuto in http://www.soccervictoria.org.au/cp2/c4/webi/article/024926ar.doc . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:kRReN8NIQtUJ:www.soccervictoria.org.au/cp2/c4/webi/article/024926ar.doc+allintitle:+leukaemia+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non ?ollegato agli autori di questa pagina e non ?esponsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle leukaemia VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Physiotherapists/Sports Trainer VSF Academy Program REPORTS TO: Head ...

VICTORIAN SOCCER FEDERATION POSITION OVERVIEW POSITION: Physiotherapists/Sports Trainer VSF Academy Program REPORTS TO: Head Coach CURRENT INCUMBENT: VACANT DIRECT REPORTS: n/a AREAS OF RESPONSIBILITY: Vision, Mission & Core Values Demonstrate an understanding and action the Vision, Mission and core values of the Victorian Soccer Federation (VSF). Teamwork Demonstrate a commitment to teamwork as the core platform of operation at all times. Communication Ensure communication of the right information, to the correct person, using the appropriate medium. Leadership Develop, coach, motivate and lead the VSF staff and/or volunteers to support them in meeting their professional targets. Innovation Actively contribute to creating a culture of innovation and creativity within the VSF. ...

Erstellt: 04.03.04 Letzte Änderung / Speicherung: 04.03.04 12:33 Gedruckt: 06.05.04 15:09 Dateiname : AlloRIC MMM protocol - 2004-03-04.doc The Chronic Leukaemia Working Party The MDS-Subcommittee Allogeneic stem cell transplantation after dose-reduced intensity conditioning regimen for patients with myelofibrosis with myeloid metaplasia (MMM): A phase II-study Principle Investigator: PD Dr. med. N. Kröger Bone Marrow Transplantation University Hospital Hamburg-Eppendorf Martinistraße 52 / D-20246 Hamburg / Germany Phone: +49-40-42803–4851 Fax: +49-40-42803–3795 e-mail: nkroeger@uke.uni-hamburg.de Scientific Committee: Prof. Dr. med. Dr. h. c. A. R. Zander University Hospital Hamburg-Eppendorf Hamburg, Germany Prof. Dr. Theo de Witte University Hospital Nijmegen, The Netherlands ...

leukaemia MOLECULAR RESEARCH UPDATE 17 th MAY 2004 ABSTRACT The Identification of Over-Expressed Genes in Acute Myeloid Leukaemia Farizan Aris, Mohamed Saifulaman Mohamed-Said Institute of Biotechnology, Suite 1-5, Level 5, Block 5, Science and Technology Building, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia This study was directed towards the identification of altered gene expression characteristic of Acute Myeloid Leukaemia (AML) in Malaysian patients. RNA was isolated from 10 bone marrow of adult patients at the time of diagnosis and 3 controls were subjected to oligonucleotide microarray analysis. From the genes quantified, paired t-test analysis revealed numerous genes over-expressed in a statistically significant fashion including the over-expression of known oncogenes such as member of ras family and PTTG1. Significance was denoted by a p-value of less than 0.01 and ...

Web Immagini Gruppi Directory News Novità! Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:E1psJYBUjW4J:info.imsd.uni-mainz.de/K_Krebsregister/english/texts03pdf/a3.pdf allintitle: leukaemia filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

65 0 20 40 60 80 100 120 140 160 180 200 220 Months Survival probabilities (%) 100 80 60 40 20 0 boys (n=899) girls (n=775) Age-standardized annual incidence rates (Germany: 1980-2002) Age- and sex-specific incidence rates (Germany: 1998-2002) Selected characteristics (Germany: 1998-2002) 4. Acute non-lymphocytic leukaemia Total number of cases in the registry (1980-2002): 1742 3-, 5-, and 10-year survival probabilities (Kaplan-Meier estimates): 51%, 47%, and 45% Survival probabilities by sex (Germany: 1980-2002) 0.0 0.3 0.6 0.9 1.2 1.5 1.8 <1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Girls Boys Incidence rates per 100,000 Age 0.0 0.2 0.4 0.6 0.8 1.0 1980 1982 1984 1986 1988 ...

58 0.0 1.0 2.0 3.0 4.0 5.0 1980 1983 1986 1989 1992 1995 1998 2001 Years Incidence rates per 100,000 preliminary 0 20 40 60 80 100 120 140 160 180 200 220 Months Survival probabilities (%) 100 80 60 40 20 0 <1 y. (n=225) 1- 4 y. (n=4057) 5- 9 y. (n=2394) 10-14 y. (n=1429) Age-standardized annual incidence rates (Germany: 1980-2001) Age- and sex-specific incidence rates (Germany: 1997-2001) Selected characteristics (Germany: 1997-2001) 3. Lymphoid leukaemia Total number of cases in the registry (1980-2001): 9057 3-, 5-, and 10-year survival probabilities (Kaplan-Meier estimates): 85%, 81%, and 76% Survival probabilities by age-groups (Germany: 1980-2001) 0 2 4 6 8 10 12 <1 1 2 3 4 ...

D A N I S H M E D I C A L B U L L E T I N V O L . 5 1 N O . 2 / M A Y 2 0 0 4 225 ABSTRACT OF PhD DISSERTATION Molecular changes in acute myeloid leukaemia Towards a framework for prognostication Lene Hyldahl Olesen This PhD dissertation was accepted by the Faculty of Health Sciences of the University of Aarhus, and defended on Marts 19, 2004. Official opponents: Torben Palshof, Ove Juul Nielsen and David Grimwade, United Kingdom. Tutor: Peter Hokland, Jan Maxwell Nørgaard and MSc Per Guldberg. Correspondence: Lene Hyldahl Olesen, Department of Haematology, Aarhus Sygehus, DK-8000 Aarhus C. E-mail: lene.hyldahl.olesen@aas.auh.dk Dan Med Bull 2004;51:225. ABSTRACT The present PhD dissertation was carried out at the Department of Haematology, University of Aarhus, Aarhus, Denmark, and is based ...

leukaemia High Voltage Lines Linked to Leukaemia Around 100,000 homes in the UK could have potentially dangerous levels of electromagnetic radiation - such as emitted from pylons - according to latest research. The National Radiation Protection Board said one case of childhood leukaemia every two years might be associated with living near power lines. But the National Radiological Protection Board, the Government's radiation watchdog, also said 80 per cent of homes with strong electromagnetic fields are not close to pylons. They had been working to establish whether there is a link between cancer and high-voltage overhead power lines. Their findings acknowledge an increased danger of life-threatening disease which could be blamed on living near power lines - but said they could not be sure. They estimate 100,000 homes had levels of electromagnetic fields which might contribute to two cases of childhood leukaemia each ...

leukaemia THE CHRONIC LEUKAEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION (EBMT) PATIENT CONSENT FORM Title of project: EBMT PHASE III RANDOMIZED STUDY OF DONOR LYMPHOCYTE INFUSIONS (DLI) VS. IMATINIB FOLLOWED BY DLI FOR RELAPSE AFTER ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML). The participant should complete the whole of this sheet him or herself. (please tick each statement if it applies to you) < > I have read the Information Sheet for Patients. < > I have been given the opportunity to ask questions and discuss this study. < > I have received satisfactory answers to all my questions. < > I have received enough information about the study The study has been explained to me by: Prof./Dr./Mr./Mrs/Ms < > I understand that I am free to withdraw ...

leukaemia 2005 Guidelines on the Management of Chronic Myeloid Leukaemia European Leukaemia Network Produced by O?Brien, Cervantes, Thaler, Gratwohl, Hochhaus, Guilhot, Baccarani, Simonsson, Hehlman on behalf of the European Investigators on Chronic Myeloid Leukaemia . BCSH members tbc. Funded by FP6 etc, WP 4 & 18 These guidelines and supplementary material are available on the internet at www.etc? Timetable 31st May 2004 Content structure agreed by core writing group (based on enclosed ) June & July Draft document created by core writing committee. I am happy to produce the first substantive draft in outline and may well ask others to contribute to specific sections eg. Andreas for monitoring, Alois for ...

TOC draft 1 4 th May 2004 ELN CML Guidelines Page 1 of 5 2005 Guidelines on the Management of Chronic Myeloid Leukaemia European Leukaemia Network Produced by O’Brien, Cervantes, Thaler, Gratwohl, Hochhaus, Guilhot, Baccarani, Simonsson, Hehlman on behalf of the European Investigators on Chronic Myeloid Leukaemia . BCSH members tbc. Funded by FP6 etc, WP 4 & 18 These guidelines and supplementary material are available on the internet at www.etc Timetable 31 st May 2004 Content structure agreed by core writing group (based on enclosed ) June & July Draft document created by core writing committee. I am happy to produce the first substantive draft in outline and may well ask others to contribute to specific sections eg. Andreas for monitoring, Alois for BMT etc. 1 st August 2004 ...

C:\TEMP\Temporary Internet Files\OLK5E1\applicationformsupdatedfebruary2004.doc Application for a UKCCSG/Childhood Leukaemia Working Party Biological Study Section One - Details of applicant(s) 1. Applicant(s) - Name(s) and Title(s): 2. Name and address of lead applicant: Tel No: Fax No: E-mail: Section Two - Details of the project 3. Title of research project: 4. Expected duration of the project: 5. Proposed start date: 6. Aims and objectives of the project (please include the hypothesis to be tested) Page 1 of 3 Page 2 2 7. Scientific background to the research (use more space if required) 8. Plan of investigation, including methodology (use more space if required) 9. Preliminary data (NB: human biological samples should ...

Haema 2004; 7(3): 363-365 Case report Extramedullary involvement in a case of acute myelomonocytic leukaemia Sotirios Papageorgiou 1 , Theofanis Economopoulos 1 , Panteleimon Kountourakis 1 , Dimitra Rontogianni 2 , Efstathios Papageorgiou 1 and Sotirios Raptis 1 1 Second Department of Internal Medicine, Propaedeutic, Athens University, Áttikon Hospital, 2 Pathology Department, Evangelismos Hospital, Athens, Greece Abstract. Granulocytic sarcomas (chloromas) are tumor masses of immature myeloid cells occurring in an extramedullary site. Organ involvement by granulocytic sarcomas has been documented to be extremely variable. We describe an unusual case of acute myeloid leukaemia in a 58-year-old male presenting with a painless mass in the left neck and leukocytosis. ...

Haema 2004; 7(3): 340-344 Original article Pentostatin administration in patients with resistant/relapsing chronic lymphocytic leukaemia Stavroula N. Tsiara, Aristidis Chaidos, Leonidas Christou, Michael Tzilianos, Helen D. Kapsali, Konstantinos L. Bourantas Department of Haematology, University of Ioannina School of Medicine, Ioannina, Greece Abstract. The objective of this study was to test the efficacy of pentostatin in patients with resistant/ relapsing chronic lymphocytic leukaemia (CLL). Ten patients, 6 men 4 women, median age 71 years, range 64-78 years, in stage C, according to Binet?s classification enrolled in the study. They have been previously treated consecutively with the combination chlorambucil-prednisolone, fludarabine and CHOP. They received 2- deoxycoformycin (pentostatin), 4 mg/m 2 every other week for six cycles. Response to treatment was evaluated ...

July 1998, Vol. 27 No. 4 485 Childhood Leukaemia Integrated Psychosocial Intervention Model—B Macner-Licht et al Childhood Leukaemia : Towards an Integrated Psychosocial Intervention Programme in Singapore B Macner-Licht,* MPH, MSocWk , V Rajalingam,** MBBS, M Med (Paed) , V Bernard-Opitz,*** PhD (Psych) Abstract A hospital-based behavioural intervention programme was developed for families of children with newly diagnosed or relapsed Acute Lymphoblastic Leukaemia (ALL). The programme’s aim was to enhance the families’ ability to cope with the emotionally distressing aspects of the illness and the medical treatment. Eight children and 10 parents participated in the programme for 12 weeks. The children received individual therapeutic play sessions and computer-assisted distraction activities, while the parents participated in ...

Leuk Lymphoma 2001 Jan;40(3-4):393-403 Gamma-linolenic acid induces apoptosis in B-chronic lymphocytic leukaemia cells in vitro. Mainou-Fowler T, Proctor SJ, Dickinson AM University Department of Haematology, School of Clinical, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK. [Medline record in process] Gamma linolenic acid (GLA) is cytotoxic to many types of human cancer cells. Most chemotherapeutic agents are cytotoxic by inducing apoptosis. We examined the apoptotic activity of GLA on purified B-cells isolated from patients with B-cell chronic lymphocytic leukaemia (B-CLL) and from normal individuals. GLA significantly increased the degree of apoptosis in B-CLL B-cells after 24 hours of culture. The mean percentage of cells undergoing apoptosis when cultured in medium alone (spontaneous apoptosis) was 20% (range: 7 to 31%) (n=25) and in the presence of GLA (5 microg-60 microg) was: ...

Guidelines on the diagnosis and management of chronic lymphocytic leukaemia Methods The purpose of this guideline is to provide a rational approach to the diagnosis and management of patients with chronic lymphocytic leukaemia (CLL). This guideline has been compiled by the Guidelines Working Group of the UK CLL Forum on behalf of the British Committee for Standards in Haematology (BCSH). Recommendations are based on a review of the literature using Medline/Pubmed searches under the heading, CLL, up to October 2003 and data presented at the American Society of Hematology in 2003 and at the 10th International Workshop on CLL in 2003. The results of meta-analyses and phase 3 studies that have been published or presented in abstract form are included. Treatment recommendations were influenced by current and proposed clinical trials in the UK and by guidance from The National Institute ...

DEVON AIR AMBULANCE TRUST Registered Charity No. 1077998 Registered Office: Unit 5 Sandpiper Court Harrington Lane Pinhoe Exeter EX4 8NS (£2000 will be donated to Sure Start Registered Charity No: 25301) OFFICIAL SPONSORSHIP FORM EVENT: - 2 nd June 2004 A 5km Exeter City Charity Run organized by Michelmores Solicitors NAME AND ADDRESS OF PERSON BEING SPONSORED: If the people who sponsor you are tax payers Devon Air Ambulance Trust can claim the tax back. This means an extra 28p in the pound for the charity . Please help us by ticking the box on the sponsorship form and asking your sponsors to clearly write their full name and address. Name and address of Sponsor Amount per km Amount Paid GIFT AID (please tick) 18 Cathedral Yard Exeter EX1 1HE Telephone: 01392 ...